Get the top three things to know in women's health + wellness, every weekday:

Less Than 1 Percent of Insurers Have Guidance for Postpartum Depression Drug

What: Stateline’s Nada Hassanein investigates coverage for the first postpartum depression drug and finds that only 17 insurers–less than 1 percent of the 1,000 insurance companies in the country–have published coverage guidance. The new medication, Zurzuvae, recently hit the market and costs $16,000.

Why it matters: As Hassanein reports, Medicaid covers 41% of births nationwide, and many state Medicaid agencies haven’t yet said if they’ll cover the medication. Which means many women who may need this drug can’t get it yet.

SourceStateline

More News Snippets
The Texas OB-GYN Exodus  

In one example, the University of Texas Rio Grande Valley’s entire OB-GYN department is shutting down, highlighting the severity of the crisis.

Menopause and Muscle Pain

How hormonal changes during menopause, particularly the decline in estrogen levels, can lead to muscle pain and body aches.

The Infertility Panic in America

Looking at infertiity rates in the wake of Trump administration officials, like top health nominee RFK Jr., claiming that it is on the rise.

Medicare and Medicaid in Oz

Donald Trump has nominated Dr. Mehmet Oz to lead Medicare and Medicaid–the country’s massive health insurance programs for the elderly and lower-income adults and children.

Saving the Tiniest Babies

Advances in neonatal care now make it possible to save extremely premature babies, some born as early as 22 weeks.